A substantial body of literature, most of which involves tumor or neuropathological conditions, demonstrates that iASPP is a direct target gene of miR-124 (Liu et al., 2013; Chen et al., 2014; Liang et al., 2017; Liu et al., 2018). This evidence concerns the gene PPP1R13L and neoplasm.